Effects of CDK6 regulated by miR‑298 on proliferation and apoptosis of thyroid cancer cells

Abstract

Effects of CDK6 regulated by miR-298 on proliferation and apoptosis of thyroid cancer cells were explored. Seventy-five cases of thyroid carcinoma and adjacent tissues were collected. The expression levels of miR-298 and CDK6 mRNA in tissues and cells were detected by RT-PCR. In addition, thyroid cancer cells and human normal thyroid cells Nthy-ori3-1 were purchased, with the former transfected with miR-298-mimics, miR-298-inhibitor, miR-NC, si-CDK6, si-NC, Sh-CDK6, Sh-NC to build cell models. Then the expression levels of miR-298 and CDK6 in thyroid cancer tissues and cells were detected by qRT-PCR, and the expression of CDK6, Bax, Bcl-2 and caspase-3 by WB. CCK-8 and flow cytometry were employed to detect cell proliferation and apoptosis, and dual luciferase report was adopted to determine the relationship between miR-298 and CDK6. miR-298 was underexpressed in thyroid cancer, and CDK6 was highly expressed in thyroid cancer. Cell experiments revealed that overexpression of miR-298 or inhibition of CDK6 expression could suppress cell proliferation, promote apoptosis, and significantly increase the expression levels of Bax and caspase-3 proteins, decrease Bcl-2 protein expression, which was contrary to the biological phenotype of cells after inhibition of miR-298 or further overexpression of CDK6. Dual luciferase report confirmed that miR-298 was a targeting site of CDK6. miR-298 can inhibit the proliferation of thyroid cells and promote apoptosis of thyroid cancer cells by regulating the expression of CDK6, which is expected to be a potential target for clinical application.

Introducing Circulating Vasculature-Related Transcripts as Biomarkers in Coronary Artery Disease

“…Function and pathway enrichment analysis of the circulating vasculature transcripts in the present study were associated with response to an organic substance, regulation of different cell population proliferation, regulation of gene expression, and mononuclear cell migration, consistent with many previous results [19,20,[91][92][93][94][95].…”

YTHDC1 aggravates high glucose-induced retinal vascular endothelial cell injury via m6A modification of CDK6

“…Li et al [ 25 ] reported that P27 inhibited CDK6 expression, leading to cell cycle arrest and inhibiting cell proliferation. MiR-298 could target the expression of CDK6 to inhibit the proliferation of thyroid cells and promote the apoptosis of thyroid cancer cells [ 26 ]. Chen et al [ 27 ] found that miRNA-524-5p could negatively regulate CDK6 expression, inhibit osteosarcoma cell proliferation and induce cell cycle arrest.…”